Efficacy and safety of Nephritis rehabilitation tablet combined with Valsartan for chronic glomerulonephritis: A system review and meta-analysis

Journal of Hainan Medical University(2022)

Cited 0|Views5
No score
Abstract
Objective: To systematically evaluate the efficacy and safety of Nephritis Rehabilitation Tablet (NRT) combined with valsartan in treatment of chronic glomerulonephritis (CGN). Methods: Computer search databases such as CNKI, CBM, VIP, wanfang, Embase, PubMed and Cochrane library, and find all randomized controlled trials (RCTs) comparing NRT combined with valsartan versus valsartan in treatment of chronic glomerulonephritis. The search time limit is to build the database until October 2020. RCTs were screened according to the inclusion and exclusion criteria. After data extraction and quality assessment, the Cochrane risk of bias tool was used to evaluate the methodological quality of these studies. Meta-analysis was performed by Review Manager 5.2, and GRADE system for evidence quality evaluation. Results: We have identified a total of 24 eligible RCTs with 2082 participants and completed a meta-analysis based on these RCTs. The results of the meta-analysis showed that compared with valsartan, NRT combined with valsartan treatment showed effective curative effect in terms of effective treatment rate (OR = 4.72; 95%CI, 3.67, 6.08; P < 0.00001), 24h urine protein quantification (MD = -0.52; 95%CI, -0.59, -0.44; P < 0.00001), serum creatinine (Scr) (MD = -10.33; 95%CI, -14.00, -6.66; P < 0.00001), Systolic blood pressure (SBP) (MD = -11.42; 95%CI, -17.67, -5.17; P = 0.0003), Diastolic blood pressure (DBP) (MD = -6.28; 95%CI, -9.14, -3.42; P < 0.0001), Blood urine nitrogen (BUN) (MD = -0.02; 95% CI, -0.41, 0.37; P = 0.93), plasma albumin (ALB) (MD = 5.05; 95% CI, 4.27, 5.84; P < 0.00001), and adverse reactions (OR = 0.93, 95% CI, 0.54, 1.60; P = 0.78). No serious adverse events were mentioned in these studies. And based on the results of the systematic review, the GRADE system recommended ranking method was used to evaluate the quality of evidence and the recommendation level. The results showed that the level of evidence was moderate and the recommendation intensity was weak recommendation. Conclusions: NRT combined with valsartan has a significant effect on the treatment of CGN, and the treatment effect is better than valsartan alone. There are no obvious adverse reactions during the treatment process. However, due to the generally low quality of the literature included in these studies, and the variability of the evaluation methods of each study, morelarge samples, multi-center, high-quality samples are still needed RCTs are further verified.
More
Translated text
Key words
Nephritis rehabilitation tablet,Valsartan,Chronic glomerulonephritis,Randomized controlled trial,Meta-analysis
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined